QT prolongation risk with antiemetics during COVID 19 treatment

Int J Clin Pract. 2021 May;75(5):e14041. doi: 10.1111/ijcp.14041.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiemetics* / adverse effects
  • COVID-19 Drug Treatment*
  • Electrocardiography
  • Humans
  • Long QT Syndrome* / chemically induced
  • Risk Factors
  • SARS-CoV-2

Substances

  • Antiemetics